Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Development of Siglec-9 Blocking Antibody to Enhance Anti-Tumor Immunity
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-11-19
DOI
10.3389/fonc.2021.778989
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sialic Acids and Their Influence on Human NK Cell Function
- (2021) Philip Rosenstock et al. Cells
- Inhibitory Receptors and Checkpoints in Human NK Cells, Implications for the Immunotherapy of Cancer
- (2020) Simona Sivori et al. Frontiers in Immunology
- Siglec-9 Regulates an Effector Memory CD8+ T-cell Subset That Congregates in the Melanoma Tumor Microenvironment
- (2019) Quentin Haas et al. Cancer Immunology Research
- Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial
- (2019) Kayvon Modjarrad et al. LANCET INFECTIOUS DISEASES
- Sugar Free: Novel Immunotherapeutic Approaches Targeting Siglecs and Sialic Acids to Enhance Natural Killer Cell Cytotoxicity Against Cancer
- (2019) John Daly et al. Frontiers in Immunology
- PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells
- (2019) Silvia Pesce et al. Frontiers in Immunology
- Sialic acid–binding immunoglobulin-like lectins (Siglecs) detect self-associated molecular patterns to regulate immune responses
- (2019) Heinz Läubli et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Decreased erythrocyte binding of Siglec-9 increases neutrophil activation in sickle cell disease
- (2019) Zachary M. Kiser et al. BLOOD CELLS MOLECULES AND DISEASES
- Synthetic nucleic acid antibody prophylaxis confers rapid and durable protective immunity against Zika virus challenge
- (2019) Hyeree Choi et al. Human Vaccines & Immunotherapeutics
- Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins
- (2018) Kim F. Bornhöfft et al. DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
- Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
- (2018) Shetal A. Patel et al. IMMUNITY
- Decreased Siglec-9 Expression on Natural Killer Cell Subset Associated With Persistent HBV Replication
- (2018) Di Zhao et al. Frontiers in Immunology
- Hypersialylation in Cancer: Modulation of Inflammation and Therapeutic Opportunities
- (2018) Emily Rodrigues et al. Cancers
- Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
- (2018) Michal A. Stanczak et al. JOURNAL OF CLINICAL INVESTIGATION
- Synthetic DNA-Encoded Monoclonal Antibody Delivery of Anti–CTLA-4 Antibodies Induces Tumor Shrinkage In Vivo
- (2018) Elizabeth K. Duperret et al. CANCER RESEARCH
- Engineered DNA Vaccination against Follicle-Stimulating Hormone Receptor Delays Ovarian Cancer Progression in Animal Models
- (2018) Alfredo Perales-Puchalt et al. MOLECULAR THERAPY
- Immune-checkpoint inhibitors for combating T-cell dysfunction in cancer
- (2018) Ewelina Grywalska et al. OncoTargets and Therapy
- MUC1 Mucin: A Putative Regulatory (Checkpoint) Molecule of T Cells
- (2018) Babita Agrawal et al. Frontiers in Immunology
- Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and function
- (2017) John P. Veluchamy et al. Scientific Reports
- Siglec-7 restores β-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes
- (2017) Gitanjali Dharmadhikari et al. Scientific Reports
- The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9
- (2016) Richard Beatson et al. NATURE IMMUNOLOGY
- The Fab Fragment of a Human Anti-Siglec-9 Monoclonal Antibody Suppresses LPS-Induced Inflammatory Responses in Human Macrophages
- (2016) Sasa Chu et al. Frontiers in Immunology
- Sialic acids in cancer biology and immunity
- (2015) Oliver M T Pearce et al. GLYCOBIOLOGY
- Therapeutic Targeting of Siglecs using Antibody- and Glycan-Based Approaches
- (2015) Takashi Angata et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Siglec receptors impact mammalian lifespan by modulating oxidative stress
- (2015) Flavio Schwarz et al. eLife
- Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance
- (2014) Camilla Jandus et al. JOURNAL OF CLINICAL INVESTIGATION
- Multifarious roles of sialic acids in immunity
- (2012) Ajit Varki et al. Annals of the New York Academy of Sciences
- Siglecs and Immune Regulation
- (2012) Shiv Pillai et al. Annual Review of Immunology
- Sialoglycoproteins adsorbed by Pseudomonas aeruginosa facilitate their survival by impeding neutrophil extracellular trap through siglec-9
- (2012) B. Khatua et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
- (2010) Jennifer A. Belisle et al. Molecular Cancer
- Siglecs as targets for therapy in immune-cell-mediated disease
- (2009) Mary K. O’Reilly et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Siglec-9 enhances IL-10 production in macrophages via tyrosine-based motifs
- (2008) Munetoshi Ando et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More